Insiders Trades
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Latest filing published 27 May 2026 for Recursion Pharmaceuticals, INC.. Read the official filing
Filing timeline
BuySaleChristopher Gibson
Insider track record
Disclosed buys
0
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Christopher Gibson: trading record in brief
Filings by Christopher Gibson span 2 companies, the busiest being Recursion Pharmaceuticals, Inc. and Pacific Biosciences of California, Inc. Between 21 November 2021 and 22 May 2026, the trades on record add up to 110 filings.
Every open-market trade on record is a sale: 4 sales worth €1.1M. Other entries cover 21 share grants and 30 option exercises. 2026 to date brings no purchases and 3 sales.
The newest entry dates from 27 May 2026: a transaction, in Recursion Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Christopher Gibson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations110 total
40,000 shares0Class A Common StockSEC:0001856369-26-000019:0
40,000 shares@ US$3.080.0075% mcap2.3% of flowClass A Common StockSEC:0001856369-26-000019:1
40,000 shares0Class A Common StockSEC:0001856369-26-000013:0
40,000 shares@ US$3.610.0069% mcap2.6% of flowClass A Common StockSEC:0001856369-26-000013:1
57,473 shares0Common StockSEC:0001856369-26-000010:0
40,000 shares0Class A Common StockSEC:0001856369-26-000008:0
40,000 shares@ US$3.102.2% of flowClass A Common StockSEC:0001856369-26-000008:1
40,000 shares0Class A Common StockSEC:0001601830-26-000052:0
20,000 shares0Class A Common StockSEC:0001601830-26-000049:0
53,913 shares0Common StockSEC:0001299130-26-000050:0
27,265 shares@ US$3.491.0% of flowClass A Common StockSEC:0001601830-26-000021:0
40,000 shares0Class A Common StockSEC:0001601830-26-000008:0
40,000 shares0Class A Common StockSEC:0001856369-26-000005:0
60,000 shares0Class A Common StockSEC:0001856369-26-000003:0
40,000 shares0Class A Common StockSEC:0001856369-25-000018:0
60,000 shares0Class A Common StockSEC:0001856369-25-000016:0
40,390 shares@ US$4.141.8% of flowClass A Common StockSEC:0001856369-25-000014:0
60,000 shares0Class A Common StockSEC:0001856369-25-000012:0
100,000 shares0Class A Common StockSEC:0001856369-25-000010:0
120,000 shares0Class A Common StockSEC:0001856369-25-000007:0
100,000 shares0Class A Common StockSEC:0001856369-25-000005:0
120,000 shares0Class A Common StockSEC:0001601830-25-000145:0
100,000 shares0Class A Common StockSEC:0001601830-25-000136:0
40,390 shares@ US$5.642.4% of flowClass A Common StockSEC:0001601830-25-000132:0
423,666 shares0Class A Common StockSEC:0001601830-25-000130:0
25 of 110 declarations
